Is LLY a good stock to buy? We came across a bullish thesis on Eli Lilly and Company on Investomine’s Substack. In this ...

Eli Lilly (NYSE:LLY) stock is down 5% in Tuesday afternoon trading, with shares falling to $937 from a prior close of $989.12 ...

Eli Lilly (LLY) stock drops as HSBC downgrades the company warning that weight-loss drugmaker could be “priced to perfection.

The analyst now thinks that expectations for obesity drugs’ total addressable market are elevated at over $150 billion. ・While the oral obesity pill launch might expand access to anti-obesity ...

Eli Lilly (LLY) stock is lower today, after HSBC downgraded it to "reduce" from "hold," citing an inflated obesity drug market ...

With short-term returns turning negative, analysts are reassessing Lilly's high valuation, reminding the market that even dominant corporations are susceptible to sharp..

Eli Lilly (LLY) stock declined after HSBC downgrade to Reduce with $850 price target, citing obesity drug market risks and ...

Eli Lilly (NYSE:LLY) shares have pulled back sharply, falling  9% over the past month, and 13% year-to-date. Most Wall Street analysts remain constructive, with a consensus price target of $1,216.93 ...

Eli Lilly's soaring stock price has sparked 2026 split speculation. Here's what a potential LLY split could mean and what investors should consider now.

HSBC downgraded this dividend-paying health care giant. Here's what investors should know before the obesity drug race heats ...

The way that people discuss LLY these days is virtually unique. Quieter tones—almost like a mutual understanding among investors that something important is happening inside Eli Lilly’s labs—rather ...

Biggest stock gainers. Lemonade +15% - Shares gained after Morgan Stanley upgraded the stock to Overweight from Equal-Weight, citi ...